Product NDC: | 0049-3190 |
Proprietary Name: | VFEND |
Non Proprietary Name: | VORICONAZOLE |
Active Ingredient(s): | 10 mg/mL & nbsp; VORICONAZOLE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0049-3190 |
Labeler Name: | Roerig |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021267 |
Marketing Category: | NDA |
Start Marketing Date: | 20030328 |
Package NDC: | 0049-3190-01 |
Package Description: | 20 mL in 1 VIAL, SINGLE-USE (0049-3190-01) |
NDC Code | 0049-3190-01 |
Proprietary Name | VFEND |
Package Description | 20 mL in 1 VIAL, SINGLE-USE (0049-3190-01) |
Product NDC | 0049-3190 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | VORICONAZOLE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20030328 |
Marketing Category Name | NDA |
Labeler Name | Roerig |
Substance Name | VORICONAZOLE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |